New Research Presented at Leading Cardiology Conference
Filed with ASX · · 2 pages · English
Sydney, Australia: AI and Medical Technology company ECHOIQ Limited (“Echo IQ”, the Company) (ASX:EIQ) is pleased to announce that the research and findings underpinning the company’s latest AI-algorithm have been presented as late-breaking science at the world’s foremost cardiology conference, the European Society of Cardiology (ESC) Congress, in Barcelona, Spain. On 28 August, Professor Geoffrey
Earlier from EchoIQ
- New Clinical Study with World-Leading US Teaching Hospital
- Updated Appendix 4C Quarterly Cash Flow Report
- Quarterly Activities/Appendix 4C Cash Flow Report - June
- Presentation of Research Findings Behind Echo IQ Algorithm
- Sale of Prometheus Information Pty. Limited
Later from EchoIQ
- Suspension from Official Quotation
- Echo IQ Selected for HeartX Accelerator & Funding
- Reinstatement to Official Quotation
- Quarterly Activities/Appendix 4C Cash Flow Report - Sept
- Amendment to Appendix 4C
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ